Altmetric – Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial

Title	Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial
Published in	Trials, March 2021
DOI	10.1186/s13063-021-05116-9
Pubmed ID	33648568
Authors	Jan Maláska, Jan Stašek, František Duška, Martin Balík, Jan Máca, Jan Hruda, Tomáš Vymazal, Olga Klementová, Jan Zatloukal, Tomáš Gabrhelík, Pavel Novotný, Regina Demlová, Jana Kubátová, Jana Vinklerová, Adam Svobodník, Milan Kratochvíl, Jozef Klučka, Roman Gál, Mervyn Singer

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Unknown	1	100%

Type	Count	As %
Members of the public	1	100%

Mendeley readers

The data shown below were compiled from readership statistics for 264 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	264	100%

Readers by professional status	Count	As %
Student > Bachelor	29	11%
Researcher	24	9%
Student > Master	23	9%
Student > Ph. D. Student	14	5%
Student > Postgraduate	13	5%
Other	37	14%
Unknown	124	47%

Readers by discipline	Count	As %
Medicine and Dentistry	71	27%
Nursing and Health Professions	17	6%
Pharmacology, Toxicology and Pharmaceutical Science	9	3%
Psychology	5	2%
Agricultural and Biological Sciences	4	2%
Other	27	10%
Unknown	131	50%

Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol…